Cargando…
AB125. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
BACKGROUND: There is no consensus regarding whether androgen deprivation therapy (ADT) is associated with cardiovascular disease (CVD) and cardiovascular mortality (CVM). The objective of this study was to determine the role of ADT for prostate cancer (PCa) in development of cardiovascular events (C...
Autores principales: | Niu, Yuanjie, Zhu, Shimiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708692/ http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s125 |
Ejemplares similares
-
AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016) -
AB167. The protective effect of KH-204 in androgen-deprived male rat
por: Bae, Woong Jin, et al.
Publicado: (2015) -
AB153. The antioxidant effect of the herbal formulation in the bladder of androgen deprivation-induced rat
por: Bae, Woong Jin, et al.
Publicado: (2015) -
Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies
por: Zhao, Jinsheng, et al.
Publicado: (2014) -
AB116. Research of efficacy of brachytherapy for localized prostate cancer
por: Wang, Tianyu, et al.
Publicado: (2015)